Lv6
2622 积分 2022-04-11 加入
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
4天前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
8天前
已完结
In vivo enhancement of tumour-specific T cells via peptide–MHC-pseudotyped retroviral gene delivery
10天前
已完结
cHS4 insulator-mediated alleviation of promoter interference during cell-based expression of tandemly associated transgenes
10天前
已完结
Tumor penetrating peptides for improved drug delivery
11天前
已完结
In vivo CRISPR screens identify key modifiers of CAR T cell function in myeloma
17天前
已完结
In vivo CAR engineering for immunotherapy
19天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
19天前
已完结
Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization
22天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
皖公网安备34019202002308
